{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:04:19Z","timestamp":1782421459299,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["2019xxxx0054"],"award-info":[{"award-number":["2019xxxx0054"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.biopha.2023.114228","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T16:53:53Z","timestamp":1673110433000},"page":"114228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Canagliflozin inhibits inflammasome activation in diabetic endothelial cells\u00a0\u2013 Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin\u00a0on human diabetic endothelial cells"],"prefix":"10.1016","volume":"159","author":[{"given":"Xiaoling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela P.","family":"Kerindongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Preckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Ole","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus W.","family":"Hollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coert J.","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina C.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2023.114228_bib1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med"},{"issue":"16","key":"10.1016\/j.biopha.2023.114228_bib2","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1111\/bph.15850","article-title":"Amelioration of endothelial dysfunction by sodium glucose co-transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection","volume":"179","author":"Li","year":"2022","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114228_bib3","doi-asserted-by":"crossref","first-page":"2527406","DOI":"10.1155\/2018\/2527406","article-title":"Advanced glycation end products enhance murine monocyte proliferation in bone marrow and prime them into an inflammatory phenotype through MAPK signaling","volume":"2018","author":"Jin","year":"2018","journal-title":"J. Diabetes Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.114228_bib4","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the heart failure society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biopha.2023.114228_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00109-016-1481-5","article-title":"Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction","volume":"94","author":"Chen","year":"2016","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.114228_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41419-020-2598-6","article-title":"High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.biopha.2023.114228_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081808","article-title":"The NLRP3 inflammasome: metabolic regulation and contribution to inflammaging","volume":"9","author":"Meyers","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.biopha.2023.114228_bib8","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2023.114228_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071477","article-title":"TNF-Alpha may mediate inflammasome activation in the absence of bacterial infection in more than one way","volume":"8","author":"Alvarez","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ckj\/sfz137","article-title":"Tumor necrosis factor-alpha blockade ameliorates diabetic nephropathy in rats","volume":"14","author":"Cheng","year":"2021","journal-title":"Clin. Kidney J."},{"issue":"2","key":"10.1016\/j.biopha.2023.114228_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020314","article-title":"NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes","volume":"10","author":"Gora","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.biopha.2023.114228_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","article-title":"NLRP3 inflammasome in endothelial dysfunction","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.biopha.2023.114228_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/cvr\/cvy304","article-title":"Innate immunity as a target for acute cardioprotection","volume":"115","author":"Zuurbier","year":"2019","journal-title":"Cardiovasc Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib14","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin inhibits interleukin-1beta-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2023.114228_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.33594\/000000178","article-title":"Empagliflozin and dapagliflozin reduce ROS generation and restore NO bioavailability in tumor necrosis factor alpha-stimulated human coronary arterial endothelial cells","volume":"53","author":"Uthman","year":"2019","journal-title":"Cell Physiol. Biochem"},{"issue":"5","key":"10.1016\/j.biopha.2023.114228_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","article-title":"Cardiac microvascular endothelial enhancement of cardiomyocyte function is impaired by inflammation and restored by empagliflozin","volume":"4","author":"Juni","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2023.114228_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116044","article-title":"Sodium glucose Co-Transporter 2 inhibitors ameliorate endothelium barrier dysfunction induced by cyclic stretch through inhibition of reactive oxygen Species","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.114228_bib18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10557-020-07083-w","article-title":"Novel anti-inflammatory effects of canagliflozin involving hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells","volume":"35","author":"Uthman","year":"2021","journal-title":"Cardiovasc Drugs Ther."},{"issue":"15","key":"10.1016\/j.biopha.2023.114228_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158777","article-title":"Canagliflozin inhibits human endothelial cell inflammation through the induction of heme oxygenase-1","volume":"23","author":"Peyton","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114228_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112515","article-title":"Empagliflozin reduces oxidative stress through inhibition of the novel inflammation\/NHE\/[Na(+)]c\/ROS-pathway in human endothelial cells","volume":"146","author":"Uthman","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12933-022-01480-1","article-title":"Direct cardiac effects of SGLT2 inhibitors","volume":"21","author":"Chen","year":"2022","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.biopha.2023.114228_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.820541","article-title":"Canagliflozin ameliorates NLRP3 inflammasome-mediated inflammation through inhibiting NF-kappaB signaling and upregulating Bif-1","volume":"13","author":"Niu","year":"2022","journal-title":"Front. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2023.114228_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3892\/etm.2022.11569","article-title":"Citrulline protects against LPSinduced acute lung injury by inhibiting ROS\/NLRP3dependent pyroptosis and apoptosis via the Nrf2 signaling pathway","volume":"24","author":"Xue","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2023.114228_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108053","article-title":"Targeting the NLRP3 inflammasome in cardiovascular diseases","volume":"236","author":"Toldo","year":"2022","journal-title":"Pharm. Ther."},{"issue":"44","key":"10.1016\/j.biopha.2023.114228_bib25","doi-asserted-by":"crossref","first-page":"37919","DOI":"10.1074\/jbc.M111.251777","article-title":"Ca2+ influx through reverse mode Na+\/Ca2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1\/2 activation and angiogenic functions of human endothelial cells","volume":"286","author":"Andrikopoulos","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114228_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cellsig.2017.05.013","article-title":"Coupling between the TRPC3 ion channel and the NCX1 transporter contributed to VEGF-induced ERK1\/2 activation and angiogenesis in human primary endothelial cells","volume":"37","author":"Andrikopoulos","year":"2017","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41420-022-00906-9","article-title":"HDAC11 promotes both NLRP3\/caspase-1\/GSDMD and caspase-3\/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells","volume":"8","author":"Yao","year":"2022","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.biopha.2023.114228_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41419-017-0257-3","article-title":"Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.114228_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.freeradbiomed.2021.01.053","article-title":"Chronic intermittent hypoxia-induced mitochondrial dysfunction mediates endothelial injury via the TXNIP\/NLRP3\/IL-1beta signaling pathway","volume":"165","author":"Yan","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"15","key":"10.1016\/j.biopha.2023.114228_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153138","article-title":"Activated protein C ameliorates tubular mitochondrial reactive oxygen species and inflammation in diabetic kidney disease","volume":"14","author":"Rana","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.114228_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.277","article-title":"K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells","volume":"6","author":"Yaron","year":"2015","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.114228_bib32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)\/H(+) exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"issue":"15","key":"10.1016\/j.biopha.2023.114228_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025328","article-title":"Sodium-Glucose cotransporter 2 inhibitor canagliflozin antagonizes salt-sensitive hypertension through modifying transient receptor potential channels 3 mediated vascular calcium handling","volume":"11","author":"Zhao","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13046-018-0714-6","article-title":"TNFalpha induces Ca(2+) influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells","volume":"37","author":"Zhu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2023.114228_bib35","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.1301974","article-title":"Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function","volume":"192","author":"Ghonime","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114228_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000263","article-title":"Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of origin","volume":"2","author":"Scott","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2023.114228_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fphar.2019.00362","article-title":"Canagliflozin inhibits human endothelial cell proliferation and tube formation","volume":"10","author":"Behnammanesh","year":"2019","journal-title":"Front. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib38","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006277","article-title":"Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) inflammasome activation in heart failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2023.114228_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113409","article-title":"Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK\/NF-kappaB\/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis","volume":"153","author":"Nasr","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2023.114228_bib41","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.ATV.18.8.1199","article-title":"Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus","volume":"18","author":"Nilsson","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114228_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5099\/aj100100001","article-title":"Upregulation of TNF-alpha and receptors contribute to endothelial dysfunction in zucker diabetic rats","volume":"2","author":"Gao","year":"2010","journal-title":"Am. J. Biomed. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2023.114228_bib43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/1346-8138.13398","article-title":"Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: a 6-month prospective study","volume":"43","author":"Pina","year":"2016","journal-title":"J. Dermatol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:44:48Z","timestamp":1773387888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"alternative-id":["S0753332223000161"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114228","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canagliflozin inhibits inflammasome activation in diabetic endothelial cells\u00a0\u2013 Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin\u00a0on human diabetic endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114228"}}